These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23671009)

  • 1. Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism.
    Gary T; Belaj K; Bruckenberger R; Hackl G; Hafner F; Froehlich H; Zebisch A; Pilger E; Brodmann M
    Obesity (Silver Spring); 2013 Sep; 21(9):E463-6. PubMed ID: 23671009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
    Hirmerova J; Ulcova-Gallova Z; Seidlerova J; Filipovsky J; Bibkova K; Micanova Z; Mayer O
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):318-25. PubMed ID: 19221100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism].
    Liu FF; Zhai ZG; Yang YH; Wang J; Wang C
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1860-3. PubMed ID: 24124734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
    Stojanovich L; Kontic M; Djokovic A; Ilijevski N; Stanisavljevic N; Marisavljevic D
    Scand J Rheumatol; 2012 May; 41(3):223-6. PubMed ID: 22324785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease.
    Piantoni S; Andreoli L; Allegri F; Meroni PL; Tincani A
    Reumatismo; 2012 Dec; 64(5):307-13. PubMed ID: 23256106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V; Bison E; Ruffatti A; Iliceto S
    Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy.
    Ogunyemi D; Cuellar F; Ku W; Arkel Y
    Am J Perinatol; 2003 Jan; 20(1):17-24. PubMed ID: 12638077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events.
    Campello E; Zabeo E; Radu CM; Spiezia L; Gavasso S; Fadin M; Woodhams B; Vettor R; Simioni P
    Thromb Haemost; 2015 Jan; 113(1):85-96. PubMed ID: 25318550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
    Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
    J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.
    Simonin L; Pasquier E; Leroyer C; Cornec D; Lemerle J; Bendaoud B; Hillion S; Pers JO; Couturaud F; Renaudineau Y
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):14-27. PubMed ID: 27342459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry.
    Weingarz L; Schwonberg J; Schindewolf M; Hecking C; Wolf Z; Erbe M; Weber A; Lindhoff-Last E; Linnemann B
    Br J Haematol; 2013 Dec; 163(5):655-65. PubMed ID: 24219332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
    Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of haemostatic alterations in overweight children with weight loss due to lifestyle intervention.
    Fritsch P; Kleber M; Schlagenhauf A; Laschnik B; Fritsch M; Muntean W; Mangge H; Reinehr T
    Atherosclerosis; 2011 May; 216(1):170-3. PubMed ID: 21334626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study.
    Delluc A; Le Moigne E; Tromeur C; Noel-Savina E; Couturaud F; Mottier D; Le Gal G; Lacut K
    Br J Haematol; 2011 Aug; 154(4):486-91. PubMed ID: 21671893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight, obesity, and the risk of recurrent venous thromboembolism.
    Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
    Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.